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ABSTRACT  1 
Objectives. To assess stability and contribution of a large extended spectrum β-lactamase 2 
(ESBL)-containing IncI1 plasmid to intestinal colonization by Escherichia coli O104:H4 in two 3 
different mammalian hosts.  4 
Methods. Specific-pathogen-free 3-day old New Zealand White rabbits and conventionally-5 
reared 6-week-old weaned lambs were orally infected with wild-type E. coli O104:H4 or the 6 
ESBL-plasmid cured derivative, and the recovery of bacteria in intestinal homogenates and 7 
faeces monitored over time.  8 
Results. Carriage of the ESBL plasmid had differing impacts on E. coli O104:H4 colonisation of 9 
the two experimental hosts. The plasmid cured strain was recovered at significantly higher 10 
levels than wild type during late-stage colonization of rabbits, but at lower levels than wildtype 11 
in sheep.  Regardless of the animal host, the ESBL plasmid was stably maintained in virtually all 12 
in vivo passaged bacteria that were examined.  13 
Conclusions. These findings suggest that carriage of ESBL plasmids has distinct effects on the 14 
host bacterium depending upon the animal species it encounters and demonstrates that, as for 15 
E. coli O157:H7, ruminants could represent a potential transmission reservoir. 16 
  17 
INTRODUCTION 18 
 In 2011, Escherichia coli O104:H4 caused a large outbreak of haemolytic uraemic 19 
syndrome centred in northern Germany, in which more than 50 people died.1 Subsequent 20 
genotypic and phenotypic analyses demonstrated that this strain was unusual, with features of 21 
both enterohaemorrhagic (EHEC) and enteroaggregative E. coli (EAEC) pathotypes.2, 3 Typical of 22 
all EHEC, the strain contained genes coding for Shiga toxin (Stx), specifically Stx2a, which is 23 
associated with severe clinical outcome in patients.4 However, it also adhered to tissue culture 24 
cells in a characteristic ‘stacked-brick’ manner, a trait that defines the EAEC pathotype and is 25 
associated with aggregative adherence fimbriae, the genes for which are carried on a plasmid 26 
(pAA). Unusual for both pathotypes, E. coli O104:H4 harboured a large plasmid carrying genes 27 
coding for extended-spectrum β-lactamases (ESBLs).  While several studies have focused on the 28 
contribution of pAA to E. coli O104:H4 pathogenesis5-7, none have considered the significance 29 
of ESBL plasmid carriage beyond its immediate impact limiting antibiotic options. 30 
  ESBLs are enzymes that confer resistance to many front-line β-lactam antibiotics and 31 
are a dominant mechanism of antimicrobial resistance in Gram negative bacteria.8  Many types 32 
of ESBL have been described, but those belonging to the CTX-M type, have become widespread 33 
in the UK and elsewhere.9-12  Genes encoding ESBLs are most often located on large, 34 
conjugative plasmids, in part providing a mechanistic explanation for their spread.8 Bacterial 35 
carriage of resistance plasmids such as those encoding ESBLs, is believed to confer a biological 36 
fitness cost to the host bacterium, although experimental evidence to support this is conflicting. 37 
In vitro-based growth assays have shown both detrimental13 and no fitness cost14-15 associated 38 
with carriage of CTX-M-containing plasmids. However, Schaufler and colleagues concluded that 39 
ESBL plasmid carriage was only associated with a fitness cost when bacteria were grown on 40 
surfaces rather than as planktonic cultures.16  In their study, surface-associated plasmid-cured 41 
variants of various pathogenic E. coli clonal lineages exhibited changes in fimbriae production, 42 
an ability to form biofilms or be motile; surface-associated attributes that may contribute to 43 
colonisation and persistence in the mammalian intestine.  44 
Given the widespread prevalence of ESBL-producing organisms that are also pathogens 45 
of animals and/or humans, it is perhaps surprising that more studies to examine their impact in 46 
the context of the host have not been performed. Moreover, evidence to indicate whether 47 
ruminants act as a reservoir for EAEC,17 or Shiga toxin-producing EAEC isolates such as E. coli 48 
O104:H418  is lacking, although carriage following experimental infection of calves has recently 49 
been demonstrated.19  Herein, we describe the impact of pESBL, the IncI1 plasmid of E. coli 50 
O104:H4, on the capacity of the pathogen to colonise the intestine of two different mammalian 51 
species. Plasmid carriage hindered late-stage colonisation of the intestine of infant rabbits, a 52 
model of EHEC-mediated intestinal disease in humans.20  In contrast, E. coli O104:H4 persisted 53 
in the intestine and could be detected in faeces of weaned sheep for up to 4 weeks, 54 
independently of pESBL carriage. These studies indicate that carriage of a large ESBL plasmid 55 
mediated host-specific differences in the persistence of the host bacterium and demonstrate 56 
that, as for E. coli O157:H7,21, 22 ruminants could represent a potential transmission source. 57 
 58 
MATERIALS AND METHODS 59 
Strains and culture conditions. The strains and plasmids used in the study are listed in Table S1. 60 
BL211, a Stx2 deletion mutant of E. coli O104:H4 strain C227-115, was used in this study to 61 
enable the animal experiments to be performed in the available facilities and reduce any risk of 62 
serious infection to research personnel.  Bacteria were routinely grown in LB medium or on LB 63 
agar plates containing the appropriate antibiotics: gentamicin 10 µg/mL; tetracycline 10 µg/mL 64 
or cefotaxime 2 µg/mL.   65 
Construction of the pESBL cured derivative. Strain BL211 harbours 3 plasmids including a large 66 
88.5 kb ESBL-encoding plasmid that belongs to incompatibility group I1 (IncI1) and carries both 67 
the blaTEM-1 and blaCTX-M-15 genes2 (subsequently annotated as blaCTX-M-323).  Incompatibility-68 
based curing13 was used to rid strain BL211 of this plasmid (originally referred to as pESBL-EA11 69 
and herein called pESBL). Briefly, plasmid pIFM27, a sacB-containing plasmid, which encodes 70 
the IncI1 plasmid replication down-regulator RNAI that directly interferes with the replication of 71 
IncI plasmids, was introduced into BL211 by electroporation. Transformants were selected on 72 
LB agar supplemented with kanamycin (50 µg/mL) and were subsequently screened for an 73 
inability to grow on cefotaxime-containing LB media. Curing of plasmid pIFM27 from 74 
cefotaxime-susceptible colonies was accomplished by recovery of colonies on LB-agar 75 
supplemented with 5% sucrose. Subsequently, sucrose-resistant, cefotaxime-susceptible 76 
colonies were screened for loss of pESBL and pIFM27 by PCR and plasmid profiling (Figure S1A-77 
B).  Loss of pESBL did not impact the ability of the strain (herein called BL320) to grow in vitro in 78 
LB media in single strain growth assays (Figure S1C).  79 
PCR analysis of colonies. Multiplex PCR was used to assess the chromosomal and plasmid gene 80 
content of BL211, BL320 and randomly selected colonies recovered from rabbits or sheep 81 
infected with the parental strain BL211. Primer sequences, expected product sizes and reaction 82 
conditions are reported in Table S1.  83 
Infant rabbit studies. All experimental protocols were approved by the local Animal Welfare 84 
Ethical Review Body, and carried out in accordance with the UK Animals (Scientific Procedures) 85 
Act 1986.  86 
Time-mated specific pathogen free adult New Zealand White rabbits were purchased 87 
from Harlan Laboratories (Derby, UK) at 2-3 weeks gestation. Following partition, mixed sex 88 
litters were kept together in a nesting box with the lactating doe and housed under standard 89 
conditions. Infant rabbit infections were performed on 3 to 4-day-old pups essentially as 90 
described previously.5  Briefly, rabbits were administered ranitidine intraperitoneally (5 mg/kg 91 
body weight) and 2 hours later ~1 x 109 cfu bacteria re-suspended in sodium bicarbonate 92 
solution (2.5g NaHCO3 in 100mL H2O) was given via oral gavage. Following challenge, animals 93 
were monitored twice daily for signs of intestinal disease. Given that all bacterial strains lacked 94 
Stx, clinical signs were scored with the following revised scale: none (no adherent faecal 95 
material on fur and intestines appear normal with hard, formed digesta in the distal colon), 96 
intestinal disease (no adherent faecal material on fur but colon contains soft, poorly-formed 97 
digesta) and diarrhoea (adherent faecal material on fur and colon contains liquid or unformed 98 
digesta).  Rabbits were euthanased by a Schedule 1 method at either day 3 or day 7 post 99 
infection. Tissues were aseptically sampled post-mortem for bacterial enumeration. Samples 100 
from the distal small intestine, caecum, mid- and distal- colon, and stool were homogenised in 101 
PBS, serially diluted and plated onto LB agar supplemented with gentamicin and tetracycline. 102 
Where no colonies were detected following plating of undiluted tissue homogenates, the 103 
number of bacteria recovered was set using the lower limit of detection as a value. Spread 104 
plates, which contained well-spaced colonies, were chosen for replica-plating to LB agar with 105 
and without cefotaxime. Colonies failing to grow on the antibiotic were subject to multiplex 106 
PCR to confirm the loss of blaCTX-M. All infections were performed in at least 2 independent 107 
litters in order to limit any litter-specific effects. 108 
Sheep colonisation studies. All experimental protocols were approved by the local Animal 109 
Welfare Ethical Review Body, and carried out in accordance with the UK Animals (Scientific 110 
Procedures) Act 1986.  111 
Experimentally-inoculated, weaned sheep were used as a model of natural ruminant 112 
infection as previously described for E. coli O157:H7.24,25  Conventionally-reared 6-week-old 113 
cross-bred commercial lambs were divided into mixed sex groups of 8 animals and housed 114 
under bio-secure conditions. Prior to challenge, individual sheep were confirmed as free of E. 115 
coli O104:H4 by screening faecal samples with an in-house E. coli O104-specific 116 
immunomagnetic separation (IMS) capture assay and an agglutination assay.26  After one week 117 
acclimation, sheep were orally inoculated with ~5 x109 cfu of bacteria (BL211 or BL320) 118 
delivered in a volume of 11 ml using a worming gun (Novartis, UK). The inocula were prepared 119 
from 16 hr aerobically incubated cultures, which were grown in LB broth, pelleted by 120 
centrifugation and finally re-suspended in PBS. Faecal samples were collected per rectum from 121 
all animals on days 1 to 14 post infection (PI) and twice weekly thereafter until day 39. On days 122 
4 and 39 PI, 3 and 5 animals respectively from each group were euthanased and tissue samples 123 
(1 g) were collected from the ileum, caecum, spiral colon, rectum and recto-anal junction.  Prior 124 
to microbiological analysis, faecal and tissue samples were homogenised in buffered peptone 125 
water (BPW) at a ratio of 1:10 (weight/volume) using a vortex (faeces) or an Ystral D-79282 126 
homogenizer (tissues). Ten-fold serial dilutions of the homogenised samples were plated 127 
directly onto sorbitol MacConkey agar plates supplemented with tetracycline and gentamicin. If 128 
no colonies were observed after overnight incubation, samples were enriched by incubating the 129 
BPW homogenates at 37˚C for 18 h followed by re-plating to provide a qualitative result.  130 
Selected colonies from all faecal and tissue samples were screened by multiplex PCR as 131 
described above.  132 
Statistical analysis.  The presence or absence of disease in rabbits was expressed in a 133 
contingency table and analysed using Fisher’s Exact test. Bacterial count data (cfu/g) were log 134 
transformed and differences in the number of wild-type or cured cells recovered in each 135 
intestinal section compared using Student’s t-test. In the sheep infection studies, bacterial 136 
count data were log transformed and the total cfu shed over days 1 to 4 (8 animals per group) 137 
or days 5 to 39 (5 animals per group) were calculated using AUC following the trapezoidal rule 138 
(GraphPad Prism, version 5). Differences in the AUC of strains were compared using Student’s t-139 
test. All statistical analysis was performed using GraphPad Prism (version 5). 140 
 141 
RESULTS 142 
Previously, the E. coli O104:H4 outbreak strain was shown to colonize the infant rabbit intestine 143 
and cause diarrhoea in a manner that was dependent on Stx, but independent of pAA, the 144 
plasmid responsible for mediating aggregative adherence on cultured cells.5 The contribution of 145 
the 88.5 kb β-lactamase-encoding plasmid (pESBL) of E. coli O104:H4 pathobiology was not 146 
explored. Stable maintenance of pESBL during in vitro growth23 may indicate that pESBL plays 147 
an important role in the organism’s biology. In order to investigate this further, we cured pESBL 148 
from the Shiga toxin negative derivative of E. coli O104:H4 and examined its contribution to 149 
colonisation of rabbit and sheep intestines.  150 
  151 
pESBL hinders E. coli O104:H4 long term colonisation of infant rabbits. Consistent with earlier 152 
findings5, oral infection of infant rabbits with the Shiga toxin negative derivative caused few 153 
visible signs of disease.  Loose stools were detected in 18% (3 of 17) and 11% (2 of 19) of 154 
animals infected with the wildtype and plasmid-cured strain respectively, between days 2-3 155 
post inoculation (PI) (Table S2). Since the majority of animals did not exhibit any manifestations 156 
of diarrhoea, we focused on the role of the plasmid in bacterial colonisation of the rabbit 157 
intestine. 158 
The distribution and number of challenge E. coli present in the intestine of rabbits 159 
infected with BL211 or BL320 were determined at days 3 and day 7 PI (Figure 1A-D). Regardless 160 
of the infecting strain, there were no differences in the number of BL211 or BL320 cfu 161 
recovered from these regions at day 3 PI. In contrast, by day 7 PI, 1-2 logs fewer BL211 than 162 
BL320 were recovered in all regions of the intestine.  Specifically, colonisation of the parent 163 
strain BL211 was significantly reduced compared to the pESBL-cured strain in the ileum (160-164 
fold; P<0.01), caecum (215-fold; P<0.01) and was lower but did not reach statistical significance 165 
in the colon (mid colon 95-fold; P=0.07) and distal colon (50-fold; P=0.13) of infected rabbits. 166 
These findings suggest that carriage of pESBL hinders the longer-term persistence of E. coli 167 
O104:H4 particularly in the upper regions of the rabbit intestine.    168 
In order to investigate whether pESBL was stably maintained in the wild type strain 169 
during infection, representative colonies recovered from each animal were replica-plated onto 170 
media supplemented with/without cefotaxime.  Loss of ESBL activity was rarely found, even 171 
after 7 days growth in the intestine. In all, approx. 2.5 x103 colonies recovered at either day 3 or 172 
day 7 PI were screened for growth on cefotaxime-containing media, and only 1 colony 173 
(recovered at day 3) failed to grow on the antibiotic-containing media. Loss of blaCTX-M in this 174 
colony was confirmed by PCR (see Figure S1A). Together these observations suggest that while 175 
pESBL hinders the ability of the host bacterium to persist in the rabbit intestine, the plasmid is 176 
stably maintained in the cell.  177 
pESBL aids persistence in the ruminant intestine. In order to investigate the role of 178 
pESBL in colonisation of the ruminant intestine, we orally infected groups of 6-week-old 179 
conventional lambs with BL211 or BL320, and monitored the presence of bacteria up until day 180 
39 PI. Due to the lower number of bacteria usually recovered following E. coli O157:H7 181 
challenge of sheep27, an additional enrichment step was included when necessary during 182 
sample processing in these experiments. 183 
As expected, none of the infected lambs showed gross signs of disease after challenge 184 
and at post-mortem all intestinal tissues appeared normal. Regardless of the infecting strain, 185 
most animals shed high numbers of cells (>107 cfu/g) the day after challenge, declining 186 
thereafter (Figure 2A). Within each group, some animals continuously shed the challenge 187 
bacteria whereas others showed intermittent shedding or only shed for a few days. However, 188 
the magnitude and duration of faecal shedding in BL211-infected animals was generally greater 189 
than for BL320-infected animals (Figure 2A). The median time before the number of shed 190 
bacteria fell below experimental detection limits in two consecutive samples collected from the 191 
same animal was 35 (range 4 to 35) and 18 (range 10 to 21) days for BL211 and BL320, 192 
respectively (Figure 2A, inset). As a result, higher numbers of bacteria were recovered from 193 
animals infected with BL211 compared to BL320 in the later stages of the infection. Moreover, 194 
bacteria were more likely to be recovered by direct plating rather than following overnight 195 
enrichment of faecal samples from animals infected with BL211 versus BL320 (Figure 2B).  196 
Despite these trends, the magnitude and duration of shedding when expressed as the area 197 
under the curve (AUC) for each strain approached but did not reach statistical significance 198 
(P=0.08).  Thus, the presence of pESBL appears to prolong the duration of E. coli O104:H4 199 
shedding in sheep, albeit with high inter-animal variability.  200 
While E. coli O157:H7 preferentially colonises the mid- to lower intestinal tract of 201 
sheep,24,27 the site of E. coli O104:H4 colonisation is less well-defined. Thus, samples from 202 
different regions of the intestine (ileum, caecum, colon, rectum and anal-rectal junction) were 203 
collected from infected animals at day 4 (n=3) and day 39 (n=5) PI. At day 4 PI, low levels of 204 
challenge bacteria were recovered from all five sites of the intestine and all animals, regardless 205 
of the infecting strain, yielded bacteria from at least two intestinal sites. While more bacteria 206 
tended to be recovered from animals infected with the parent strain BL211, the tissue 207 
distribution did not differ markedly between the two strains (Table S3), or from E. coli 208 
O157:H7.24  At day 39 PI, challenge bacteria could no longer be recovered, even with 209 
enrichment, from any of the intestinal samples collected, even though the organisms could still 210 
be detected in the animals’ faeces.   As found during the rabbit challenge experiments, the 211 
ESBL-producing plasmid was stably maintained in colonies recovered from the sheep. 212 
Consistent with reports from human infection7, at least one colony was found to lack aggR 213 
indicative of pAA loss.  214 
DISCUSSION. While a considerable amount of work has been performed elucidating the genetic 215 
and biochemical basis of ESBL resistance, fewer studies have attempted to uncover the 216 
contribution of ESBL-containing plasmids to pathogen biology, particularly in context of 217 
bacterial survival and carriage in animal hosts.  By generating a plasmid-cured derivative of Stx-218 
negative ESBL-producing E. coli O104:H4, we were able to assess the impact of ESBL plasmid 219 
carriage in two complementary animal hosts: infant rabbits, which are used as a model of Stx-220 
mediated intestinal disease5, 20 and weaned sheep, which are a potential ruminant reservoir 221 
host of Stx-producing isolates.28  We found that carriage of pESBL affected the fitness of the 222 
bacterium in the intestine of the two experimental hosts, with the cured strain being recovered 223 
at higher levels than wild type in rabbits but at lower levels (than wildtype) in sheep. Our 224 
findings challenge the idea that fitness costs are consistent across different assays as reported 225 
previously.29  While Vogwill and colleagues29 found a significant correlation between fitness 226 
scores assessed using in vitro and in vivo assays, the impact of the host was not fully 227 
ascertained in their analyses. All the in vivo studies examined in their study were performed in a 228 
single host species, mice. Our findings highlight the importance of the host context when 229 
considering the impact of resistance plasmids on the fitness of the bacterium during intestinal 230 
carriage.  231 
Species-specific differences in the host can mitigate the requirement for particular 232 
bacterial factors and may explain the differing impact of pESBL on the host bacterium in this 233 
study.  For example, gltA, encoding a citrate synthase and mtlD, encoding a mannitol metabolic 234 
protein, are important for effective Vibrio cholerae colonisation of the infant rabbit but not the 235 
infant mouse intestine.30  Differences in the availability of carbon and energy sources within the 236 
two animal intestines were hypothesised to explain the relative necessity of these genes. 237 
Likewise, differences between the rabbit and sheep gastrointestinal tracts could impact the 238 
contribution of plasmid-borne factors on BL211 fitness.  In addition to the ESBL genes which are 239 
unlikely to confer a direct selective advantage in our experiments, pESBL contains 95 genes 240 
coding for factors of unknown and known function. One of these is Hha, a haemolysin 241 
expression-modulating protein that appears to affect a myriad of surface-associated cellular 242 
phenotypes in E. coli including bacterial motility, cell aggregation and biofilm formation.31 Loss 243 
of Hha in laboratory K12 and some ESBL-producing E. coli isolates led to increased swimming 244 
activity and reduced biofilm formation compared to their parental strains16; phenotypes that 245 
may alter the ability of the organism to colonise and persist in the intestine.   246 
The late-stage colonisation advantage of the pESBL cured strain was not evident in 247 
sheep, a ruminant host.  Instead, it appeared that loss of pESBL resulted in more rapid 248 
clearance of the cured strain from the intestine than wild type (Figure 2). Only detailed 249 
molecular analyses involving deletion mutants and further in vivo experimentation will uncover 250 
the factors and/or mechanisms that explain these fitness outcomes. Like the prototypical E. coli 251 
O157:H7 serotype, we found that E. coli O104:H4 was able to persist in the ruminant intestine 252 
for at least 4 weeks.  These findings are consistent with those recently reported following 253 
experimental infection of E. coli O104:H4 in weaned calves.19 254 
Finally, we found that pESBL was stably maintained during infection, as most cells 255 
recovered from the rabbit or sheep intestine retained the ability to grow on cefotaxime-256 
containing media. Similar observations were reported for calves infected with E. coli O104:H419, 257 
for pigs infected with E. coli carrying an IncI/ST12 blaCTX-M-encoding plasmid32 and most 258 
recently, in streptomycin-treated mice infected with E. coli carrying a large non-conjugative 259 
virulence plasmid.33 As noted by others, why these large plasmids are stably maintained in the 260 
host bacterium in the absence of obvious selection pressure is intriguing.  Yamaichi and 261 
colleagues identified 6 regions of pESBL as essential for pESBL replication or segregation.23 262 
Intriguingly one of these regions mapped to hha.  Thus, as well as hha potentially affecting the 263 
surface-expressed properties of the host bacterium, its’ presence may also help to ensure that 264 
pESBL is stably maintained in the cell during intestinal growth. Unlike some other IncI ESBL 265 
plasmids circulating in the UK10, pESBL also appears to contain a recognisable plasmid addiction 266 
system (PndAC). While not identified as playing a role in plasmid maintenance in E. coli 267 
O104:H423, PndAC has been found to play a role in the maintenance of other plasmids.34, 35  268 
Collectively our studies suggest that the impact of plasmids bearing antibiotic resistance 269 
determinants on pathogen biology needs to be understood in the context of the host. For 270 
zoonotic food-borne pathogens, this should include intestinal environments that are healthy 271 
(i.e. reservoir hosts) or diseased, as host factors such as inflammatory cells36, are known to 272 
affect AMR transmission and pathogen survival. Finally, our studies show that ruminants such 273 
as sheep can act as reservoir hosts for E. coli O104:H4, and thus they should be considered as a 274 
potential source of transmission to humans.  275 
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Figure 1 384 
 385 
Figure 1. Recovery of bacteria in infant rabbits orally infected with E. coli O104:H4 or a 386 
derivative lacking pESBL. Concentration (cfu/g) of bacteria recovered at 3 and 7 days post 387 
infection in intestinal homogenates of rabbits infected with the indicated strain (wild-type 388 
BL211 and pESBL-cured strain, BL320). Data points represent individual animals (at day 3: 389 
BL211, n=19 and BL320, n=17; at day 7: BL211, n=6 and BL320, n=9) and the bar represents the 390 
geometric mean. Statistical analysis was performed using Student’s t-test with P≤0.05 deemed 391 
significant. 392 
  393 
Figure 2 394 
 395 
Figure 2. Faecal shedding of E. coli O104:H4 or the pESBL-cured derivative from orally infected 396 
six-week old conventional weaned lambs. Mixed sex lambs (n=8 per group) were group-397 
housed and individual faecal samples collected per rectum. Samples were homogenised in 398 
buffered peptone water and plated directly, or after 18-hour enrichment, on SMAC media 399 
supplemented with appropriate antibiotics. Count data were log transformed and the mean 400 
(+/- standard error) number of bacteria recovered for each strain was expressed over time (A). 401 
Inset figure shows boxplots representing the median, lower and upper quartiles, and the 402 
Inset 
minimum and maximum duration of shedding for each strain. DL = experimental limit of 403 
detection based on average weight of tissue. The proportion of faecal samples in which bacteria 404 
were not found or recovered directly or following enrichment (B). 405 
 406 
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 408 
